What are the current evidence-based guidelines for adjusting anticoagulant therapy based on INR levels in patients with atrial fibrillation?
Fuente:
Zenodo
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Recurso digital |
| Pubblicazione: |
Zenodo
2025
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1866901228008505344 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | INR monitoring is essential when using warfarin for AF, with specific guidelines for adjusting doses. DOACs, offering ease without routine INR monitoring, are recommended for most patients with poor INR control on warfarin. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_17964478 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | What are the current evidence-based guidelines for adjusting anticoagulant therapy based on INR levels in patients with atrial fibrillation? Tripdatabase anticoagulant therapy INR levels atrial fibrillation evidence-based guidelines anticoagulation management INR monitoring is essential when using warfarin for AF, with specific guidelines for adjusting doses. DOACs, offering ease without routine INR monitoring, are recommended for most patients with poor INR control on warfarin. |
| title | What are the current evidence-based guidelines for adjusting anticoagulant therapy based on INR levels in patients with atrial fibrillation? |
| topic | anticoagulant therapy INR levels atrial fibrillation evidence-based guidelines anticoagulation management |
| url | https://doi.org/10.5281/zenodo.17964478 |